(1->4)-beta-D-glucan multiple interactions ISO RGD:1313496 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ZBTB16 mRNA CTD PMID:36331819 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of ZBTB16 mRNA CTD PMID:30723492 17beta-estradiol multiple interactions ISO RGD:1352454 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of ZBTB16 mRNA, [Progesterone co-treated with Estradiol] results in increased expression of ZBTB16 mRNA CTD PMID:17404688 , PMID:30165855 17beta-estradiol affects expression EXP 6480464 Estradiol affects the expression of ZBTB16 mRNA CTD PMID:32145629 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:1352454 6480464 Dihydrotestosterone results in increased expression of ZBTB16 mRNA CTD PMID:29581250 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1313496 6480464 Tetrachlorodibenzodioxin results in increased expression of ZBTB16 mRNA CTD PMID:24058054 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of ZBTB16 mRNA CTD PMID:32109520 , PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of ZBTB16 mRNA CTD PMID:22298810 3,3',5,5'-tetrabromobisphenol A decreases expression ISO RGD:1313496 6480464 tetrabromobisphenol A results in decreased expression of ZBTB16 mRNA CTD PMID:35230478 3,7-dihydropurine-6-thione increases expression EXP 6480464 Mercaptopurine results in increased expression of ZBTB16 mRNA CTD PMID:23358152 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of ZBTB16 mRNA CTD PMID:28522335 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1352454 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of ZBTB16 mRNA more ... CTD PMID:28628672 4,4'-sulfonyldiphenol multiple interactions ISO RGD:1352454 6480464 [bis(4-hydroxyphenyl)sulfone co-treated with Fulvestrant] results in increased methylation of ZBTB16 gene, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of ZBTB16 mRNA CTD PMID:28628672 , PMID:31601247 4,4'-sulfonyldiphenol increases methylation ISO RGD:1352454 6480464 bis(4-hydroxyphenyl)sulfone results in increased methylation of ZBTB16 gene CTD PMID:31601247 4,4'-sulfonyldiphenol decreases expression ISO RGD:1313496 6480464 bis(4-hydroxyphenyl)sulfone results in decreased expression of ZBTB16 mRNA CTD PMID:33297965 4-amino-2,6-dinitrotoluene affects expression EXP 6480464 4-amino-2, 6-dinitrotoluene affects the expression of ZBTB16 mRNA CTD PMID:21346803 4-hydroxyphenyl retinamide decreases expression ISO RGD:1313496 6480464 Fenretinide results in decreased expression of ZBTB16 mRNA CTD PMID:28973697 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of ZBTB16 mRNA CTD PMID:25825206 acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of ZBTB16 mRNA CTD PMID:28959563 acrylamide decreases expression ISO RGD:1352454 6480464 Acrylamide results in decreased expression of ZBTB16 mRNA CTD PMID:32763439 acrylamide decreases expression ISO RGD:1313496 6480464 Acrylamide results in decreased expression of ZBTB16 mRNA CTD PMID:30807115 Aflatoxin B2 alpha increases methylation ISO RGD:1352454 6480464 aflatoxin B2 results in increased methylation of ZBTB16 polyA tail CTD PMID:30157460 all-trans-retinoic acid decreases expression ISO RGD:1352454 6480464 Tretinoin results in decreased expression of ZBTB16 mRNA CTD PMID:15498508 more ... allethrin multiple interactions EXP 6480464 [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of ZBTB16 mRNA, [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of ZBTB16 mRNA CTD PMID:33051911 , PMID:33396045 amphotericin B decreases expression ISO RGD:1352454 6480464 Amphotericin B analog results in decreased expression of ZBTB16 mRNA CTD PMID:28534445 arsane decreases expression ISO RGD:1313496 6480464 Arsenic results in decreased expression of ZBTB16 mRNA CTD PMID:19654921 arsenic atom decreases expression ISO RGD:1313496 6480464 Arsenic results in decreased expression of ZBTB16 mRNA CTD PMID:19654921 Benoxacor decreases expression ISO RGD:1313496 6480464 benoxacor results in decreased expression of ZBTB16 mRNA CTD PMID:34850242 benzo[a]pyrene increases methylation ISO RGD:1352454 6480464 Benzo(a)pyrene results in increased methylation of ZBTB16 5' UTR more ... CTD PMID:27901495 benzo[a]pyrene decreases expression ISO RGD:1352454 6480464 Benzo(a)pyrene results in decreased expression of ZBTB16 mRNA CTD PMID:35870112 beta-naphthoflavone multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ZBTB16 mRNA CTD PMID:18164116 bexarotene increases expression EXP 6480464 bexarotene results in increased expression of ZBTB16 mRNA CTD PMID:23292798 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:1313496 6480464 Diethylhexyl Phthalate results in decreased expression of ZBTB16 mRNA CTD PMID:25975992 bis(2-ethylhexyl) phthalate increases expression EXP 6480464 Diethylhexyl Phthalate results in increased expression of ZBTB16 mRNA CTD PMID:36005737 bisphenol A affects expression ISO RGD:1352454 6480464 bisphenol A affects the expression of ZBTB16 mRNA CTD PMID:27010169 bisphenol A multiple interactions ISO RGD:1313496 6480464 [bisphenol A co-treated with Stigmasterol] results in decreased expression of ZBTB16 mRNA more ... CTD PMID:30245210 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of ZBTB16 mRNA CTD PMID:30903817 , PMID:32145629 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of ZBTB16 gene CTD PMID:28505145 bisphenol A affects methylation ISO RGD:1313496 6480464 bisphenol A affects the methylation of ZBTB16 promoter CTD PMID:27334623 bisphenol A multiple interactions ISO RGD:1352454 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] affects the expression of ZBTB16 mRNA CTD PMID:28628672 bisphenol A decreases expression ISO RGD:1352454 6480464 bisphenol A results in decreased expression of ZBTB16 mRNA CTD PMID:27685785 bisphenol A increases expression ISO RGD:1313496 6480464 bisphenol A results in increased expression of ZBTB16 mRNA CTD PMID:25594700 , PMID:34585602 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of ZBTB16 mRNA CTD PMID:25181051 more ... bromobenzene decreases expression EXP 6480464 bromobenzene results in decreased expression of ZBTB16 mRNA CTD PMID:32479839 bromobenzene increases expression EXP 6480464 bromobenzene results in increased expression of ZBTB16 mRNA CTD PMID:32479839 busulfan increases expression ISO RGD:1313496 6480464 Busulfan results in increased expression of ZBTB16 mRNA CTD PMID:26524245 buta-1,3-diene increases expression ISO RGD:1313496 6480464 1, 3-butadiene results in increased expression of ZBTB16 mRNA CTD PMID:29038090 butan-1-ol multiple interactions ISO RGD:1352454 6480464 [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of ZBTB16 mRNA CTD PMID:29432896 C60 fullerene affects expression EXP 6480464 fullerene C60 affects the expression of ZBTB16 mRNA CTD PMID:19167457 cadmium dichloride decreases expression ISO RGD:1313496 6480464 Cadmium Chloride results in decreased expression of ZBTB16 mRNA CTD PMID:24982889 carbamazepine affects expression ISO RGD:1313496 6480464 Carbamazepine affects the expression of ZBTB16 mRNA CTD PMID:22634333 carbon nanotube affects expression ISO RGD:1313496 6480464 Nanotubes more ... CTD PMID:25554681 , PMID:25620056 carbon nanotube increases expression ISO RGD:1313496 6480464 Nanotubes, Carbon results in increased expression of ZBTB16 mRNA CTD PMID:25620056 carbon nanotube decreases expression ISO RGD:1313496 6480464 Nanotubes, Carbon analog results in decreased expression of ZBTB16 mRNA CTD PMID:25554681 CGP 52608 multiple interactions ISO RGD:1352454 6480464 CGP 52608 promotes the reaction [RORA protein binds to ZBTB16 gene] CTD PMID:28238834 chloroprene increases expression ISO RGD:1313496 6480464 Chloroprene results in increased expression of ZBTB16 mRNA CTD PMID:23125180 chlorpyrifos increases expression ISO RGD:1313496 6480464 Chlorpyrifos results in increased expression of ZBTB16 mRNA CTD PMID:20350560 choline multiple interactions ISO RGD:1313496 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of ZBTB16 gene CTD PMID:20938992 cisplatin decreases expression ISO RGD:1352454 6480464 Cisplatin results in decreased expression of ZBTB16 mRNA CTD PMID:27594783 cisplatin multiple interactions ISO RGD:1352454 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of ZBTB16 mRNA CTD PMID:27392435 cocaine affects expression EXP 6480464 Cocaine affects the expression of ZBTB16 mRNA CTD PMID:20187946 crocidolite asbestos decreases expression ISO RGD:1313496 6480464 Asbestos, Crocidolite results in decreased expression of ZBTB16 mRNA CTD PMID:29279043 Cuprizon decreases expression EXP 6480464 Cuprizone results in decreased expression of ZBTB16 mRNA CTD PMID:26577399 cyclosporin A decreases expression ISO RGD:1352454 6480464 Cyclosporine results in decreased expression of ZBTB16 mRNA CTD PMID:20106945 cyclosporin A increases expression ISO RGD:1313496 6480464 Cyclosporine results in increased expression of ZBTB16 mRNA CTD PMID:19770486 cyhalothrin multiple interactions EXP 6480464 [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of ZBTB16 mRNA, [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of ZBTB16 mRNA CTD PMID:33051911 , PMID:33396045 cypermethrin multiple interactions EXP 6480464 [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of ZBTB16 mRNA, [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of ZBTB16 mRNA CTD PMID:33051911 , PMID:33396045 cypermethrin increases expression EXP 6480464 cypermethrin results in increased expression of ZBTB16 mRNA CTD PMID:35605701 cyproconazole increases expression ISO RGD:1313496 6480464 cyproconazole results in increased expression of ZBTB16 mRNA CTD PMID:22045034 dexamethasone increases expression ISO RGD:1352454 6480464 Dexamethasone results in increased expression of ZBTB16 mRNA CTD PMID:25047013 dexamethasone multiple interactions ISO RGD:1352454 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of ZBTB16 mRNA more ... CTD PMID:28628672 dibenz[a,h]anthracene increases expression ISO RGD:1313496 6480464 1 more ... CTD PMID:26377693 dibutyl phthalate increases expression ISO RGD:1313496 6480464 Dibutyl Phthalate results in increased expression of ZBTB16 mRNA CTD PMID:34280466 dichloroacetic acid decreases expression ISO RGD:1313496 6480464 Dichloroacetic Acid results in decreased expression of ZBTB16 mRNA CTD PMID:28962523 , PMID:34850242 dieldrin affects expression EXP 6480464 Dieldrin affects the expression of ZBTB16 mRNA CTD PMID:22546817 diethylstilbestrol increases expression EXP 6480464 Diethylstilbestrol results in increased expression of ZBTB16 mRNA CTD PMID:35605701 dimethylarsinic acid multiple interactions ISO RGD:1313496 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of ZBTB16 mRNA CTD PMID:34876320 dioxygen multiple interactions ISO RGD:1352454 6480464 Oxygen affects the reaction [AHR protein results in increased expression of ZBTB16 mRNA] CTD PMID:27103661 diquat increases expression ISO RGD:1313496 6480464 Diquat results in increased expression of ZBTB16 mRNA CTD PMID:36851058 dorsomorphin multiple interactions ISO RGD:1352454 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin multiple interactions ISO RGD:1313496 6480464 [[MT1 protein co-treated with MT2 protein] affects the susceptibility to Doxorubicin] which affects the expression of ZBTB16 mRNA CTD PMID:21040762 doxorubicin decreases expression ISO RGD:1352454 6480464 Doxorubicin results in decreased expression of ZBTB16 mRNA CTD PMID:29803840 doxorubicin increases expression ISO RGD:1313496 6480464 Doxorubicin results in increased expression of ZBTB16 mRNA CTD PMID:21040762 , PMID:25896364 ellagic acid decreases expression ISO RGD:1352454 6480464 Ellagic Acid results in decreased expression of ZBTB16 mRNA CTD PMID:12002526 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of ZBTB16 mRNA CTD PMID:29391264 entinostat decreases expression ISO RGD:1352454 6480464 entinostat results in decreased expression of ZBTB16 mRNA CTD PMID:26272509 entinostat multiple interactions ISO RGD:1352454 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZBTB16 mRNA CTD PMID:27188386 epoxiconazole decreases expression ISO RGD:1313496 6480464 epoxiconazole results in decreased expression of ZBTB16 mRNA CTD PMID:35436446 ethanol affects expression ISO RGD:1352454 6480464 Ethanol affects the expression of ZBTB16 mRNA CTD PMID:27010169 ethanol affects expression ISO RGD:1313496 6480464 Ethanol affects the expression of ZBTB16 mRNA CTD PMID:30319688 ethanol multiple interactions ISO RGD:1352454 6480464 [[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of ZBTB16 mRNA CTD PMID:29432896 fenvalerate multiple interactions EXP 6480464 [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of ZBTB16 mRNA, [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of ZBTB16 mRNA CTD PMID:33051911 , PMID:33396045 flusilazole affects expression ISO RGD:1313496 6480464 flusilazole affects the expression of ZBTB16 mRNA CTD PMID:22634333 folic acid multiple interactions ISO RGD:1313496 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of ZBTB16 gene CTD PMID:20938992 fulvestrant multiple interactions ISO RGD:1352454 6480464 [bis(4-hydroxyphenyl)sulfone co-treated with Fulvestrant] results in increased methylation of ZBTB16 gene CTD PMID:31601247 furan increases expression EXP 6480464 furan results in increased expression of ZBTB16 mRNA CTD PMID:25539665 , PMID:26194646 glycidol increases expression EXP 6480464 glycidol results in increased expression of ZBTB16 mRNA CTD PMID:24915197 GW 4064 decreases expression ISO RGD:1313496 6480464 GW 4064 results in decreased expression of ZBTB16 mRNA CTD PMID:26655953 , PMID:30245210 GW 4064 multiple interactions ISO RGD:1313496 6480464 bisphenol A inhibits the reaction [GW 4064 results in decreased expression of ZBTB16 mRNA] more ... CTD PMID:30245210 hexaconazole increases expression ISO RGD:1313496 6480464 hexaconazole results in increased expression of ZBTB16 mRNA CTD PMID:22045034 indole-3-methanol multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ZBTB16 mRNA CTD PMID:22129741 indometacin multiple interactions ISO RGD:1352454 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of ZBTB16 mRNA more ... CTD PMID:28628672 isoprenaline increases expression ISO RGD:1313496 6480464 Isoproterenol results in increased expression of ZBTB16 mRNA CTD PMID:20003209 isotretinoin decreases expression ISO RGD:1352454 6480464 Isotretinoin results in decreased expression of ZBTB16 mRNA CTD PMID:20436886 L-methionine multiple interactions ISO RGD:1313496 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of ZBTB16 gene CTD PMID:20938992 lipopolysaccharide decreases expression ISO RGD:1352454 6480464 Lipopolysaccharides results in decreased expression of ZBTB16 mRNA CTD PMID:35811015 lipopolysaccharide multiple interactions ISO RGD:1352454 6480464 [S-(1, 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of ZBTB16 mRNA CTD PMID:35811015 medroxyprogesterone acetate increases expression ISO RGD:1352454 6480464 Medroxyprogesterone Acetate results in increased expression of ZBTB16 mRNA CTD PMID:20843944 mercaptopurine increases expression EXP 6480464 Mercaptopurine results in increased expression of ZBTB16 mRNA CTD PMID:23358152 mercury atom increases expression ISO RGD:1352454 6480464 Mercury results in increased expression of ZBTB16 mRNA CTD PMID:19937285 mercury dibromide decreases expression ISO RGD:1352454 6480464 mercuric bromide results in decreased expression of ZBTB16 mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:1352454 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZBTB16 mRNA CTD PMID:27188386 mercury dichloride increases expression EXP 6480464 Mercuric Chloride results in increased expression of ZBTB16 mRNA CTD PMID:16507785 mercury(0) increases expression ISO RGD:1352454 6480464 Mercury results in increased expression of ZBTB16 mRNA CTD PMID:19937285 metformin increases expression EXP 6480464 Metformin results in increased expression of ZBTB16 mRNA CTD PMID:31324951 methoxychlor affects methylation EXP 6480464 Methoxychlor affects the methylation of ZBTB16 gene CTD PMID:35440735 methylarsonic acid multiple interactions ISO RGD:1313496 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of ZBTB16 mRNA CTD PMID:34876320 methylmercury chloride decreases expression ISO RGD:1352454 6480464 methylmercuric chloride results in decreased expression of ZBTB16 mRNA CTD PMID:28001369 mono(2-ethylhexyl) phthalate increases expression EXP 6480464 mono-(2-ethylhexyl)phthalate results in increased expression of ZBTB16 mRNA CTD PMID:16809437 N-acetyl-L-cysteine multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ZBTB16 mRNA CTD PMID:22129741 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ZBTB16 mRNA, [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ZBTB16 mRNA CTD PMID:18164116 , PMID:22129741 nickel atom decreases expression ISO RGD:1352454 6480464 Nickel results in decreased expression of ZBTB16 mRNA CTD PMID:24768652 , PMID:25583101 nickel sulfate increases expression ISO RGD:1313496 6480464 nickel sulfate results in increased expression of ZBTB16 mRNA CTD PMID:16166746 ozone increases expression ISO RGD:1313496 6480464 Ozone results in increased expression of ZBTB16 mRNA CTD PMID:17460151 ozone multiple interactions ISO RGD:1313496 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of ZBTB16 mRNA, [Air Pollutants results in increased abundance of Ozone] which affects the expression of ZBTB16 mRNA CTD PMID:34911549 ozone increases expression EXP 6480464 Ozone results in increased expression of ZBTB16 mRNA CTD PMID:31397875 p-chloromercuribenzoic acid decreases expression ISO RGD:1352454 6480464 p-Chloromercuribenzoic Acid results in decreased expression of ZBTB16 mRNA CTD PMID:26272509 p-chloromercuribenzoic acid multiple interactions ISO RGD:1352454 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZBTB16 mRNA CTD PMID:27188386 panobinostat multiple interactions ISO RGD:1352454 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZBTB16 mRNA CTD PMID:27188386 panobinostat decreases expression ISO RGD:1352454 6480464 panobinostat results in decreased expression of ZBTB16 mRNA CTD PMID:26272509 paracetamol affects expression ISO RGD:1313496 6480464 Acetaminophen affects the expression of ZBTB16 mRNA CTD PMID:17562736 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of ZBTB16 mRNA CTD PMID:33387578 paracetamol decreases expression ISO RGD:1352454 6480464 Acetaminophen results in decreased expression of ZBTB16 mRNA CTD PMID:22230336 paraquat increases expression ISO RGD:1313496 6480464 Paraquat results in increased expression of ZBTB16 mRNA CTD PMID:21463325 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1313496 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ZBTB16 mRNA CTD PMID:36331819 phenformin decreases expression EXP 6480464 Phenformin results in decreased expression of ZBTB16 mRNA CTD PMID:31324951 phenobarbital decreases expression ISO RGD:1313496 6480464 Phenobarbital results in decreased expression of ZBTB16 mRNA CTD PMID:23091169 phenylmercury acetate decreases expression ISO RGD:1352454 6480464 Phenylmercuric Acetate results in decreased expression of ZBTB16 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1352454 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZBTB16 mRNA CTD PMID:27188386 pirinixic acid increases expression ISO RGD:1313496 6480464 pirinixic acid results in increased expression of ZBTB16 mRNA CTD PMID:18445702 pregnenolone 16alpha-carbonitrile increases expression ISO RGD:1313496 6480464 Pregnenolone Carbonitrile results in increased expression of ZBTB16 mRNA CTD PMID:27413110 , PMID:28903501 progesterone multiple interactions ISO RGD:1352454 6480464 [Progesterone co-treated with Estradiol] results in increased expression of ZBTB16 mRNA CTD PMID:17404688 progesterone increases expression ISO RGD:1313496 6480464 Progesterone results in increased expression of ZBTB16 mRNA CTD PMID:22238285 progesterone increases expression ISO RGD:1352454 6480464 Progesterone results in increased expression of ZBTB16 mRNA CTD PMID:17404688 , PMID:20864642 progesterone affects expression ISO RGD:1313496 6480464 Progesterone affects the expression of ZBTB16 mRNA CTD PMID:17251523 propiconazole decreases expression ISO RGD:1313496 6480464 propiconazole results in decreased expression of ZBTB16 mRNA CTD PMID:21278054 purine-6-thiol increases expression EXP 6480464 Mercaptopurine results in increased expression of ZBTB16 mRNA CTD PMID:23358152 resmethrin decreases expression ISO RGD:1313496 6480464 resmethrin results in decreased expression of ZBTB16 mRNA CTD PMID:31593228 resveratrol decreases expression ISO RGD:1352454 6480464 resveratrol results in decreased expression of ZBTB16 mRNA CTD PMID:12002526 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:1352454 6480464 [S-(1, 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of ZBTB16 mRNA CTD PMID:35811015 SB 431542 multiple interactions ISO RGD:1352454 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide increases expression EXP 6480464 Silicon Dioxide results in increased expression of ZBTB16 mRNA CTD PMID:22431001 sodium arsenate multiple interactions ISO RGD:1313496 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of ZBTB16 mRNA CTD PMID:34876320 sodium arsenite increases expression ISO RGD:1313496 6480464 sodium arsenite results in increased expression of ZBTB16 mRNA CTD PMID:17682005 sodium arsenite multiple interactions ISO RGD:1313496 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of ZBTB16 mRNA CTD PMID:34876320 sodium arsenite affects methylation ISO RGD:1352454 6480464 sodium arsenite affects the methylation of ZBTB16 gene CTD PMID:28589171 stigmasterol multiple interactions ISO RGD:1313496 6480464 [bisphenol A co-treated with Stigmasterol] results in decreased expression of ZBTB16 mRNA more ... CTD PMID:30245210 stigmasterol decreases expression ISO RGD:1313496 6480464 Stigmasterol results in decreased expression of ZBTB16 mRNA CTD PMID:30245210 tamibarotene decreases expression ISO RGD:1352454 6480464 tamibarotene results in decreased expression of ZBTB16 mRNA CTD PMID:15498508 tamoxifen affects expression ISO RGD:1313496 6480464 Tamoxifen affects the expression of ZBTB16 mRNA CTD PMID:20937368 testosterone multiple interactions ISO RGD:1313496 6480464 1 more ... CTD PMID:33848595 testosterone decreases expression ISO RGD:1313496 6480464 Testosterone deficiency results in decreased expression of ZBTB16 mRNA CTD PMID:33848595 tetrachloroethene increases expression ISO RGD:1313496 6480464 Tetrachloroethylene results in increased expression of ZBTB16 mRNA CTD PMID:28973375 tetrachloromethane increases expression ISO RGD:1313496 6480464 Carbon Tetrachloride results in increased expression of ZBTB16 mRNA CTD PMID:31919559 tetraphene decreases expression ISO RGD:1313496 6480464 benz(a)anthracene results in decreased expression of ZBTB16 mRNA CTD PMID:26377693 titanium dioxide decreases expression EXP 6480464 titanium dioxide results in decreased expression of ZBTB16 mRNA CTD PMID:30012374 tremolite asbestos decreases expression ISO RGD:1313496 6480464 tremolite results in decreased expression of ZBTB16 mRNA CTD PMID:29279043 tributylstannane decreases expression ISO RGD:1313496 6480464 tributyltin results in decreased expression of ZBTB16 mRNA CTD PMID:31939706 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of ZBTB16 mRNA CTD PMID:33387578 trichostatin A decreases expression ISO RGD:1352454 6480464 trichostatin A results in decreased expression of ZBTB16 mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:1352454 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZBTB16 mRNA CTD PMID:27188386 triphenylstannane decreases expression EXP 6480464 triphenyltin results in decreased expression of ZBTB16 mRNA CTD PMID:35489455 troglitazone decreases expression ISO RGD:1313496 6480464 troglitazone results in decreased expression of ZBTB16 mRNA CTD PMID:28973697 valproic acid affects expression ISO RGD:1313496 6480464 Valproic Acid affects the expression of ZBTB16 mRNA CTD PMID:22045034 valproic acid increases expression ISO RGD:1352454 6480464 Valproic Acid results in increased expression of ZBTB16 mRNA CTD PMID:29154799 valproic acid decreases expression ISO RGD:1352454 6480464 Valproic Acid results in decreased expression of ZBTB16 mRNA CTD PMID:23179753 more ... valproic acid multiple interactions ISO RGD:1352454 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZBTB16 mRNA CTD PMID:27188386 valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of ZBTB16 mRNA CTD PMID:29427782